Chronic rejection of mouse kidney allografts

Chronic rejection of mouse kidney allografts. Chronic renal allograft rejection is the leading cause of late graft failure. However, its pathogenesis has not been defined. To explore the pathogenesis of chronic rejection, we studied a mouse model of kidney transplantation and examined the effects of...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Kidney international 1999-05, Vol.55 (5), p.1935-1944
Hauptverfasser: Mannon, Roslyn B., Kopp, Jeffrey B., Ruiz, Philip, Griffiths, Robert, Bustos, Matilde, Platt, Jeffrey L., Klotman, Paul E., Coffman, Thomas M.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 1944
container_issue 5
container_start_page 1935
container_title Kidney international
container_volume 55
creator Mannon, Roslyn B.
Kopp, Jeffrey B.
Ruiz, Philip
Griffiths, Robert
Bustos, Matilde
Platt, Jeffrey L.
Klotman, Paul E.
Coffman, Thomas M.
description Chronic rejection of mouse kidney allografts. Chronic renal allograft rejection is the leading cause of late graft failure. However, its pathogenesis has not been defined. To explore the pathogenesis of chronic rejection, we studied a mouse model of kidney transplantation and examined the effects of altering the expression of donor major histocompatibility complex (MHC) antigens on the development of chronic rejection. We found that long-surviving mouse kidney allografts develop pathological abnormalities that resemble chronic rejection in humans. Furthermore, the absence of MHC class I or class II antigens did not prevent the loss of graft function nor alter the pathological characteristics of chronic rejection. Expression of transforming growth factor-β (TGF-β), a pleiotropic cytokine suggested to play a role in chronic rejection, was markedly enhanced in control allografts compared with isografts. However, TGF-β up-regulation was significantly blunted in MHC-deficient grafts. Nonetheless, these differences in TGF-β expression did not affect the character of chronic rejection, including intrarenal accumulation of collagens. Reduced expression of either class I or II direct allorecognition pathways is insufficient to prevent the development of chronic rejection, despite a reduction in the levels of TGF-β expressed in the allograft. This suggests that the severity of chronic rejection is independent of the level of MHC disparity between donor and recipient and the level of TGF-β expression within the allograft.
doi_str_mv 10.1046/j.1523-1755.1999.00423.x
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_69742728</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0085253815461502</els_id><sourcerecordid>69742728</sourcerecordid><originalsourceid>FETCH-LOGICAL-c449t-a9dd66f7ed969c2696434d94079ddb79b0204ffa2cd8195d9acdd5c445981d0c3</originalsourceid><addsrcrecordid>eNqFkMlOwzAURS0EoqXwCygLxIoEj3G8hIpJQmIDa8v1AA4Zip2i9u9xaAXsWFlP79znqwNAhmCBIC0v6wIxTHLEGSuQEKKAkGJSrPfA9GexD6YQVizHjFQTcBRjDdMsCDwEEwQxQZTxKbiYv4W-8zoLtrZ68H2X9S5r-1W02bs3nd1kqmn616DcEI_BgVNNtCe7dwZebm-e5_f549Pdw_zqMdeUiiFXwpiydNwaUQqNS1FSQo2gkKfFgosFxJA6p7A2FRLMCKWNYSnLRIUM1GQGzrd3l6H_WNk4yNZHbZtGdTY1k6XgFHNcJbDagjr0MQbr5DL4VoWNRFCOpmQtRyFyFCJHU_LblFyn6Onuj9WiteZPcKsmAWc7QEWtGhdUp3385XiFiBgrXG8xm4R8ehtk1N522hofklBpev9_mS9CzIZQ</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>69742728</pqid></control><display><type>article</type><title>Chronic rejection of mouse kidney allografts</title><source>MEDLINE</source><source>Alma/SFX Local Collection</source><source>EZB Electronic Journals Library</source><creator>Mannon, Roslyn B. ; Kopp, Jeffrey B. ; Ruiz, Philip ; Griffiths, Robert ; Bustos, Matilde ; Platt, Jeffrey L. ; Klotman, Paul E. ; Coffman, Thomas M.</creator><creatorcontrib>Mannon, Roslyn B. ; Kopp, Jeffrey B. ; Ruiz, Philip ; Griffiths, Robert ; Bustos, Matilde ; Platt, Jeffrey L. ; Klotman, Paul E. ; Coffman, Thomas M.</creatorcontrib><description>Chronic rejection of mouse kidney allografts. Chronic renal allograft rejection is the leading cause of late graft failure. However, its pathogenesis has not been defined. To explore the pathogenesis of chronic rejection, we studied a mouse model of kidney transplantation and examined the effects of altering the expression of donor major histocompatibility complex (MHC) antigens on the development of chronic rejection. We found that long-surviving mouse kidney allografts develop pathological abnormalities that resemble chronic rejection in humans. Furthermore, the absence of MHC class I or class II antigens did not prevent the loss of graft function nor alter the pathological characteristics of chronic rejection. Expression of transforming growth factor-β (TGF-β), a pleiotropic cytokine suggested to play a role in chronic rejection, was markedly enhanced in control allografts compared with isografts. However, TGF-β up-regulation was significantly blunted in MHC-deficient grafts. Nonetheless, these differences in TGF-β expression did not affect the character of chronic rejection, including intrarenal accumulation of collagens. Reduced expression of either class I or II direct allorecognition pathways is insufficient to prevent the development of chronic rejection, despite a reduction in the levels of TGF-β expressed in the allograft. This suggests that the severity of chronic rejection is independent of the level of MHC disparity between donor and recipient and the level of TGF-β expression within the allograft.</description><identifier>ISSN: 0085-2538</identifier><identifier>EISSN: 1523-1755</identifier><identifier>DOI: 10.1046/j.1523-1755.1999.00423.x</identifier><identifier>PMID: 10231457</identifier><identifier>CODEN: KDYIA5</identifier><language>eng</language><publisher>New York, NY: Elsevier Inc</publisher><subject>Animals ; arteriosclerosis ; Biological and medical sciences ; Blotting, Northern ; Chronic Disease ; Collagen - analysis ; Collagen - immunology ; fibrosis ; Gene Expression ; Glomerular Filtration Rate ; glomerulosclerosis ; Graft Rejection - immunology ; Histocompatibility Antigens Class I - analysis ; Histocompatibility Antigens Class I - immunology ; Histocompatibility Antigens Class II - analysis ; Histocompatibility Antigens Class II - immunology ; Immunoenzyme Techniques ; Isoantigens - analysis ; Isoantigens - immunology ; Kidney - chemistry ; Kidney - immunology ; Kidney - physiology ; Kidney Transplantation ; Kidneys ; Lymphocytes - immunology ; Medical sciences ; Mice ; Mice, Inbred C57BL ; mouse MHC ; Nephrology. Urinary tract diseases ; renal graft rejection ; RNA, Messenger - analysis ; Surgery (general aspects). Transplantations, organ and tissue grafts. Graft diseases ; Surgery of the urinary system ; TGF-β ; Transforming Growth Factor beta - analysis ; Transforming Growth Factor beta - genetics ; Transforming Growth Factor beta - immunology ; transplantation ; Transplantation Immunology - immunology ; Transplantation, Homologous ; Urinary system involvement in other diseases. Miscellaneous</subject><ispartof>Kidney international, 1999-05, Vol.55 (5), p.1935-1944</ispartof><rights>1999 International Society of Nephrology</rights><rights>1999 INIST-CNRS</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c449t-a9dd66f7ed969c2696434d94079ddb79b0204ffa2cd8195d9acdd5c445981d0c3</citedby><cites>FETCH-LOGICAL-c449t-a9dd66f7ed969c2696434d94079ddb79b0204ffa2cd8195d9acdd5c445981d0c3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>309,310,314,776,780,785,786,23909,23910,25118,27901,27902</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=1781398$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/10231457$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Mannon, Roslyn B.</creatorcontrib><creatorcontrib>Kopp, Jeffrey B.</creatorcontrib><creatorcontrib>Ruiz, Philip</creatorcontrib><creatorcontrib>Griffiths, Robert</creatorcontrib><creatorcontrib>Bustos, Matilde</creatorcontrib><creatorcontrib>Platt, Jeffrey L.</creatorcontrib><creatorcontrib>Klotman, Paul E.</creatorcontrib><creatorcontrib>Coffman, Thomas M.</creatorcontrib><title>Chronic rejection of mouse kidney allografts</title><title>Kidney international</title><addtitle>Kidney Int</addtitle><description>Chronic rejection of mouse kidney allografts. Chronic renal allograft rejection is the leading cause of late graft failure. However, its pathogenesis has not been defined. To explore the pathogenesis of chronic rejection, we studied a mouse model of kidney transplantation and examined the effects of altering the expression of donor major histocompatibility complex (MHC) antigens on the development of chronic rejection. We found that long-surviving mouse kidney allografts develop pathological abnormalities that resemble chronic rejection in humans. Furthermore, the absence of MHC class I or class II antigens did not prevent the loss of graft function nor alter the pathological characteristics of chronic rejection. Expression of transforming growth factor-β (TGF-β), a pleiotropic cytokine suggested to play a role in chronic rejection, was markedly enhanced in control allografts compared with isografts. However, TGF-β up-regulation was significantly blunted in MHC-deficient grafts. Nonetheless, these differences in TGF-β expression did not affect the character of chronic rejection, including intrarenal accumulation of collagens. Reduced expression of either class I or II direct allorecognition pathways is insufficient to prevent the development of chronic rejection, despite a reduction in the levels of TGF-β expressed in the allograft. This suggests that the severity of chronic rejection is independent of the level of MHC disparity between donor and recipient and the level of TGF-β expression within the allograft.</description><subject>Animals</subject><subject>arteriosclerosis</subject><subject>Biological and medical sciences</subject><subject>Blotting, Northern</subject><subject>Chronic Disease</subject><subject>Collagen - analysis</subject><subject>Collagen - immunology</subject><subject>fibrosis</subject><subject>Gene Expression</subject><subject>Glomerular Filtration Rate</subject><subject>glomerulosclerosis</subject><subject>Graft Rejection - immunology</subject><subject>Histocompatibility Antigens Class I - analysis</subject><subject>Histocompatibility Antigens Class I - immunology</subject><subject>Histocompatibility Antigens Class II - analysis</subject><subject>Histocompatibility Antigens Class II - immunology</subject><subject>Immunoenzyme Techniques</subject><subject>Isoantigens - analysis</subject><subject>Isoantigens - immunology</subject><subject>Kidney - chemistry</subject><subject>Kidney - immunology</subject><subject>Kidney - physiology</subject><subject>Kidney Transplantation</subject><subject>Kidneys</subject><subject>Lymphocytes - immunology</subject><subject>Medical sciences</subject><subject>Mice</subject><subject>Mice, Inbred C57BL</subject><subject>mouse MHC</subject><subject>Nephrology. Urinary tract diseases</subject><subject>renal graft rejection</subject><subject>RNA, Messenger - analysis</subject><subject>Surgery (general aspects). Transplantations, organ and tissue grafts. Graft diseases</subject><subject>Surgery of the urinary system</subject><subject>TGF-β</subject><subject>Transforming Growth Factor beta - analysis</subject><subject>Transforming Growth Factor beta - genetics</subject><subject>Transforming Growth Factor beta - immunology</subject><subject>transplantation</subject><subject>Transplantation Immunology - immunology</subject><subject>Transplantation, Homologous</subject><subject>Urinary system involvement in other diseases. Miscellaneous</subject><issn>0085-2538</issn><issn>1523-1755</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1999</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFkMlOwzAURS0EoqXwCygLxIoEj3G8hIpJQmIDa8v1AA4Zip2i9u9xaAXsWFlP79znqwNAhmCBIC0v6wIxTHLEGSuQEKKAkGJSrPfA9GexD6YQVizHjFQTcBRjDdMsCDwEEwQxQZTxKbiYv4W-8zoLtrZ68H2X9S5r-1W02bs3nd1kqmn616DcEI_BgVNNtCe7dwZebm-e5_f549Pdw_zqMdeUiiFXwpiydNwaUQqNS1FSQo2gkKfFgosFxJA6p7A2FRLMCKWNYSnLRIUM1GQGzrd3l6H_WNk4yNZHbZtGdTY1k6XgFHNcJbDagjr0MQbr5DL4VoWNRFCOpmQtRyFyFCJHU_LblFyn6Onuj9WiteZPcKsmAWc7QEWtGhdUp3385XiFiBgrXG8xm4R8ehtk1N522hofklBpev9_mS9CzIZQ</recordid><startdate>19990501</startdate><enddate>19990501</enddate><creator>Mannon, Roslyn B.</creator><creator>Kopp, Jeffrey B.</creator><creator>Ruiz, Philip</creator><creator>Griffiths, Robert</creator><creator>Bustos, Matilde</creator><creator>Platt, Jeffrey L.</creator><creator>Klotman, Paul E.</creator><creator>Coffman, Thomas M.</creator><general>Elsevier Inc</general><general>Nature Publishing</general><scope>6I.</scope><scope>AAFTH</scope><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>19990501</creationdate><title>Chronic rejection of mouse kidney allografts</title><author>Mannon, Roslyn B. ; Kopp, Jeffrey B. ; Ruiz, Philip ; Griffiths, Robert ; Bustos, Matilde ; Platt, Jeffrey L. ; Klotman, Paul E. ; Coffman, Thomas M.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c449t-a9dd66f7ed969c2696434d94079ddb79b0204ffa2cd8195d9acdd5c445981d0c3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1999</creationdate><topic>Animals</topic><topic>arteriosclerosis</topic><topic>Biological and medical sciences</topic><topic>Blotting, Northern</topic><topic>Chronic Disease</topic><topic>Collagen - analysis</topic><topic>Collagen - immunology</topic><topic>fibrosis</topic><topic>Gene Expression</topic><topic>Glomerular Filtration Rate</topic><topic>glomerulosclerosis</topic><topic>Graft Rejection - immunology</topic><topic>Histocompatibility Antigens Class I - analysis</topic><topic>Histocompatibility Antigens Class I - immunology</topic><topic>Histocompatibility Antigens Class II - analysis</topic><topic>Histocompatibility Antigens Class II - immunology</topic><topic>Immunoenzyme Techniques</topic><topic>Isoantigens - analysis</topic><topic>Isoantigens - immunology</topic><topic>Kidney - chemistry</topic><topic>Kidney - immunology</topic><topic>Kidney - physiology</topic><topic>Kidney Transplantation</topic><topic>Kidneys</topic><topic>Lymphocytes - immunology</topic><topic>Medical sciences</topic><topic>Mice</topic><topic>Mice, Inbred C57BL</topic><topic>mouse MHC</topic><topic>Nephrology. Urinary tract diseases</topic><topic>renal graft rejection</topic><topic>RNA, Messenger - analysis</topic><topic>Surgery (general aspects). Transplantations, organ and tissue grafts. Graft diseases</topic><topic>Surgery of the urinary system</topic><topic>TGF-β</topic><topic>Transforming Growth Factor beta - analysis</topic><topic>Transforming Growth Factor beta - genetics</topic><topic>Transforming Growth Factor beta - immunology</topic><topic>transplantation</topic><topic>Transplantation Immunology - immunology</topic><topic>Transplantation, Homologous</topic><topic>Urinary system involvement in other diseases. Miscellaneous</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Mannon, Roslyn B.</creatorcontrib><creatorcontrib>Kopp, Jeffrey B.</creatorcontrib><creatorcontrib>Ruiz, Philip</creatorcontrib><creatorcontrib>Griffiths, Robert</creatorcontrib><creatorcontrib>Bustos, Matilde</creatorcontrib><creatorcontrib>Platt, Jeffrey L.</creatorcontrib><creatorcontrib>Klotman, Paul E.</creatorcontrib><creatorcontrib>Coffman, Thomas M.</creatorcontrib><collection>ScienceDirect Open Access Titles</collection><collection>Elsevier:ScienceDirect:Open Access</collection><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Kidney international</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Mannon, Roslyn B.</au><au>Kopp, Jeffrey B.</au><au>Ruiz, Philip</au><au>Griffiths, Robert</au><au>Bustos, Matilde</au><au>Platt, Jeffrey L.</au><au>Klotman, Paul E.</au><au>Coffman, Thomas M.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Chronic rejection of mouse kidney allografts</atitle><jtitle>Kidney international</jtitle><addtitle>Kidney Int</addtitle><date>1999-05-01</date><risdate>1999</risdate><volume>55</volume><issue>5</issue><spage>1935</spage><epage>1944</epage><pages>1935-1944</pages><issn>0085-2538</issn><eissn>1523-1755</eissn><coden>KDYIA5</coden><abstract>Chronic rejection of mouse kidney allografts. Chronic renal allograft rejection is the leading cause of late graft failure. However, its pathogenesis has not been defined. To explore the pathogenesis of chronic rejection, we studied a mouse model of kidney transplantation and examined the effects of altering the expression of donor major histocompatibility complex (MHC) antigens on the development of chronic rejection. We found that long-surviving mouse kidney allografts develop pathological abnormalities that resemble chronic rejection in humans. Furthermore, the absence of MHC class I or class II antigens did not prevent the loss of graft function nor alter the pathological characteristics of chronic rejection. Expression of transforming growth factor-β (TGF-β), a pleiotropic cytokine suggested to play a role in chronic rejection, was markedly enhanced in control allografts compared with isografts. However, TGF-β up-regulation was significantly blunted in MHC-deficient grafts. Nonetheless, these differences in TGF-β expression did not affect the character of chronic rejection, including intrarenal accumulation of collagens. Reduced expression of either class I or II direct allorecognition pathways is insufficient to prevent the development of chronic rejection, despite a reduction in the levels of TGF-β expressed in the allograft. This suggests that the severity of chronic rejection is independent of the level of MHC disparity between donor and recipient and the level of TGF-β expression within the allograft.</abstract><cop>New York, NY</cop><pub>Elsevier Inc</pub><pmid>10231457</pmid><doi>10.1046/j.1523-1755.1999.00423.x</doi><tpages>10</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0085-2538
ispartof Kidney international, 1999-05, Vol.55 (5), p.1935-1944
issn 0085-2538
1523-1755
language eng
recordid cdi_proquest_miscellaneous_69742728
source MEDLINE; Alma/SFX Local Collection; EZB Electronic Journals Library
subjects Animals
arteriosclerosis
Biological and medical sciences
Blotting, Northern
Chronic Disease
Collagen - analysis
Collagen - immunology
fibrosis
Gene Expression
Glomerular Filtration Rate
glomerulosclerosis
Graft Rejection - immunology
Histocompatibility Antigens Class I - analysis
Histocompatibility Antigens Class I - immunology
Histocompatibility Antigens Class II - analysis
Histocompatibility Antigens Class II - immunology
Immunoenzyme Techniques
Isoantigens - analysis
Isoantigens - immunology
Kidney - chemistry
Kidney - immunology
Kidney - physiology
Kidney Transplantation
Kidneys
Lymphocytes - immunology
Medical sciences
Mice
Mice, Inbred C57BL
mouse MHC
Nephrology. Urinary tract diseases
renal graft rejection
RNA, Messenger - analysis
Surgery (general aspects). Transplantations, organ and tissue grafts. Graft diseases
Surgery of the urinary system
TGF-β
Transforming Growth Factor beta - analysis
Transforming Growth Factor beta - genetics
Transforming Growth Factor beta - immunology
transplantation
Transplantation Immunology - immunology
Transplantation, Homologous
Urinary system involvement in other diseases. Miscellaneous
title Chronic rejection of mouse kidney allografts
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-01T12%3A07%3A23IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Chronic%20rejection%20of%20mouse%20kidney%20allografts&rft.jtitle=Kidney%20international&rft.au=Mannon,%20Roslyn%20B.&rft.date=1999-05-01&rft.volume=55&rft.issue=5&rft.spage=1935&rft.epage=1944&rft.pages=1935-1944&rft.issn=0085-2538&rft.eissn=1523-1755&rft.coden=KDYIA5&rft_id=info:doi/10.1046/j.1523-1755.1999.00423.x&rft_dat=%3Cproquest_cross%3E69742728%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=69742728&rft_id=info:pmid/10231457&rft_els_id=S0085253815461502&rfr_iscdi=true